NEW YORK, April 23 – Mass spectrometer developer Bruker Daltonics said Monday that the United States District Court of the District of Massachusetts has allowed its summary judgment motion of non-infringement of a Thermo Finnigan patent.

Thermo Finnigan had previously sued Bruker for infringing on its patent for its ion trap mass spectrometry, and more specifically on its mass selective instability scan. Bruker argued that its esquire ion trap mass spectrometers uses a non-linear resonance ejection scan for unsurpassed resolution, speed and sensitivity.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.